Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-17-007021)

Filing Details

Accession Number:: 0001171843-17-007021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-11-14 17:05:38
Reporting Period:: 2017-11-14

Accepted Time:: 2017-11-14 17:05:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Proteon Therapeutics Inc	PRTO	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622905	Eldridge, George Arthur	C/O Proteon Therapeutics 200 West Street Waltham MA 02451	Sr Vp, Cfo, Treasr, Asst Secy	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-14	295	$1.69	1,545	No	5	P	Indirect	As custodian for child's UTMA account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	P	Indirect	As custodian for child's UTMA account

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,750	Direct

Footnotes

These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.